biomarker-based diagnostics | GenomeWeb

biomarker-based diagnostics

Single-cell RNA sequencing on thousands of tumor and surrounding cells from 19 melanoma samples revealed subsets of cells with apparent resistance potential.

Looking beyond PD-L1 expression, investigators from several clinical trials considered a range of potential biomarkers for immune checkpoint treatment response.

The company presented its findings last week at the 2016 Gastrointestinal Cancer Symposium and is preparing to launch the assay in the US later this year.

The test could provide an early diagnosis of breast cancer by examining a handful of miRNA, microRNA, and proteomic biomarkers from urine samples. 

This summer, BioNTech Diagnostics launched MammaTyper, a CE-IVD kit for breast cancer classification that measures the expression of four genes by RT-qPCR.

The kit targets several mRNA biomarkers and is the first in a series of salivary diagnostic kits the firm plans to develop for early-stage disease diagnostics.

NEW YORK (GenomeWeb News) – C2N Diagnostics today announced a research and supplier agreement with Cambridge Isotope Laboratories to provide C2N access to large quantities of highly enriched stable isotopes.

NEW YORK (GenomeWeb News) – Metabolomics firm Metabolon and Spain's IMDEA Food today said they are collaborating on projects to develop functional foods and diagnostic tools.

NEW YORK (GenomeWeb News) – Cancer Research UK's commercial arm, Cancer Research Technology (CRT), will partner with the biomarker validation firm Abcodia to develop blood tests for detecting early-stage cancers, CRUK said today.

NEW YORK (GenomeWeb News) – Finnish biotech firm Biohit said on Monday it has agreed to buy Euroclone Gastro, a subsidiary of Italian firm Euroclone that is focused on gastrointestinal diagnostics.

Pages

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.